Therapy of Hypertension in African Americans

[1]  S. Nesbitt,et al.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. , 2010, Hypertension.

[2]  R. Grimm,et al.  Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. , 2010, American journal of hypertension.

[3]  P. Lund-johansen.  Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. , 2009, Acta medica Scandinavica.

[4]  B. Adams-Huet,et al.  Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  M. Vandervoort,et al.  A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial , 2009, Hypertension.

[6]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[7]  J. Cutler,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2008, Hypertension.

[8]  J. Flack,et al.  Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? , 2008, Current hypertension reports.

[9]  J. Aranda,et al.  Ethnic/Racial Variations in Blood Pressure Awareness, Treatment, and Control , 2007, Journal of clinical hypertension.

[10]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[11]  G. Bergus,et al.  Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure , 2006, Hypertension.

[12]  T. Malinski.  Understanding nitric oxide physiology in the heart: a nanomedical approach. , 2005, The American journal of cardiology.

[13]  S. Taler.  Treatment of resistant hypertension , 2005, Current hypertension reports.

[14]  M. Feinleib.  National Center for Health Statistics (NCHS) , 2005 .

[15]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[16]  J. Kleijnen,et al.  Systematic Review: Antihypertensive Drug Therapy in Black Patients , 2004, Annals of Internal Medicine.

[17]  T. Shafi,et al.  Determinants of Blood Pressure Response to Quinapril in Black and White Hypertensive Patients: The Quinapril Titration Interval Management Evaluation Trial , 2004, Hypertension.

[18]  A. Sehgal.  Overlap Between Whites and Blacks in Response to Antihypertensive Drugs , 2004, Hypertension.

[19]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[20]  D. Calhoun,et al.  Efficacy of low-dose spironolactone in subjects with resistant hypertension. , 2003, American journal of hypertension.

[21]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[22]  S. Oparil,et al.  Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. , 2003, Journal of the American College of Cardiology.

[23]  Susan L Ettner,et al.  Contribution of major diseases to disparities in mortality. , 2002, The New England journal of medicine.

[24]  B. Davis,et al.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.

[25]  V. Smith,et al.  The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. , 2002, Journal of the American College of Cardiology.

[26]  W. Cushman,et al.  The Effect of a Losartan‐Based Treatment Regimen on Isolated Systolic Hypertension , 2002, Journal of clinical hypertension.

[27]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[28]  N. Hollenberg,et al.  Renal perfusion and function in healthy African Americans. , 2001, Kidney international.

[29]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[30]  A. Rocchini.  Obesity hypertension, salt sensitivity and insulin resistance. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  H. Kosaka,et al.  Potassium augments vascular relaxation mediated by nitric oxide in the carotid arteries of hypertensive Dahl rats. , 2000, American journal of hypertension.

[32]  D. Sica,et al.  Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents. , 1999, Hypertension.

[33]  A. Forman,et al.  NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. , 1999, Hypertension.

[34]  I. Pörsti,et al.  Effects of calcium and potassium supplements on arterial tone in vitro in spontaneously hypertensive rats , 1998, British journal of pharmacology.

[35]  S. Sacchi,et al.  Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. , 1998, Hypertension.

[36]  C. Lang,et al.  Vasodilation in black Americans: Attenuated nitric oxide‐mediated responses , 1997, Clinical pharmacology and therapeutics.

[37]  W A Ray,et al.  Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema , 1996, Clinical pharmacology and therapeutics.

[38]  R. Prineas,et al.  Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). , 1995, Circulation.

[39]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[40]  A. Simon,et al.  Diuretics and arteriolar resistance and arterial compliance in human hypertension. , 1992, European heart journal.

[41]  V. Katch,et al.  The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. , 1989, The New England journal of medicine.

[42]  A. J. Man in't veld,et al.  Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[43]  T. Dwyer,et al.  Is obesity a major cause of chronic kidney disease? , 2004, Advances in renal replacement therapy.

[44]  R. Grimm,et al.  New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. , 2002, Ethnicity & disease.

[45]  A. Forman,et al.  Normotensive salt sensitivity: effects of race and dietary potassium. , 1999, Hypertension.

[46]  A. Rocchini,et al.  Clonidine prevents insulin resistance and hypertension in obese dogs. , 1999, Hypertension.

[47]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.